China Biotech Services Schedules 28 Aug 2026 Board Meeting to Review 1H26 Results and Potential Dividend

Bulletin Express

Aug 12

China Biotech Services Holdings Limited has issued a notice confirming that its board of directors will convene on 28 August 2026. The session will focus on two primary agenda items:

1. Approval of the unaudited condensed consolidated interim results for the six months ended 30 June 2026. 2. Consideration of a dividend payment, if any.

The board currently comprises six members—three executive directors (Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye) and three independent non-executive directors (Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao).

The announcement states that all directors accept full responsibility for the accuracy and completeness of the disclosed information. It will remain available on the Hong Kong Stock Exchange website and the company’s website for at least seven days from its publication date of 12 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/1173694839"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1173694839\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1173694839?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-12 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173694839","market":"us","top_or_hot":-1,"title":"China Biotech Services Schedules 28 Aug 2026 Board Meeting to Review 1H26 Results and Potential Dividend","media":"Bulletin Express","content":"<p>China Biotech Services Holdings Limited has issued a notice confirming that its board of directors will convene on 28 August 2026. The session will focus on two primary agenda items:</p>\n<p>1. Approval of the unaudited condensed consolidated interim results for the six months ended 30 June 2026.  \n2. Consideration of a dividend payment, if any.</p>\n<p>The board currently comprises six members—three executive directors (Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye) and three independent non-executive directors (Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao).</p>\n<p>The announcement states that all directors accept full responsibility for the accuracy and completeness of the disclosed information. It will remain available on the Hong Kong Stock Exchange website and the company’s website for at least seven days from its publication date of 12 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Biotech Services Schedules 28 Aug 2026 Board Meeting to Review 1H26 Results and Potential Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Biotech Services Schedules 28 Aug 2026 Board Meeting to Review 1H26 Results and Potential Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-12 22:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Biotech Services Holdings Limited has issued a notice confirming that its board of directors will convene on 28 August 2026. The session will focus on two primary agenda items:</p>\n<p>1. Approval of the unaudited condensed consolidated interim results for the six months ended 30 June 2026.  \n2. Consideration of a dividend payment, if any.</p>\n<p>The board currently comprises six members—three executive directors (Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye) and three independent non-executive directors (Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao).</p>\n<p>The announcement states that all directors accept full responsibility for the accuracy and completeness of the disclosed information. It will remain available on the Hong Kong Stock Exchange website and the company’s website for at least seven days from its publication date of 12 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08037","symbol_name":"中国生物科技服务","start_time":0,"source_url":"","article_id":"1173694839","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173694839","pubTimestamp":1786545776,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Biotech Services Holdings Limited has issued a notice confirming that its board of directors will convene on 28 August 2026. The session will focus on two primary agenda items: 1. Approval of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08037":"中国生物科技服务"},"translate_title":"中国生物技术服务计划于 2026 年 8 月 28 日召开董事会会议，审查 26 年上半年业绩和潜在股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"China Biotech Services Holdings Limited has issued a notice confirming that its board of directors will convene on 28 August 2026. The session will focus on two primary agenda items:\n1. Approval of the unaudited condensed consolidated interim results for the six months ended 30 June 2026.  \n2. Consideration of a dividend payment, if any.\nThe board currently comprises six members—three executive directors (Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye) and three independent non-executive directors (Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao).\nThe announcement states that all directors accept full responsibility for the accuracy and completeness of the disclosed information. It will remain available on the Hong Kong Stock Exchange website and the company’s website for at least seven days from its publication date of 12 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}